CD163 and COVID-19: Interestingly, positive CD163 immunostaining was previously reported on myocardial inflammatory infiltrates in myocarditis after COVID-19 (71, 72) and adenovirus-vectored (Ad26.COV2.S) SARS-CoV-2 vaccination (73).